Metabolic syndrome in young Czech women with polycystic ovary syndrome

Hum Reprod. 2005 Dec;20(12):3328-32. doi: 10.1093/humrep/dei221. Epub 2005 Aug 5.

Abstract

Methods: Sixty-nine young women with polycystic ovary syndrome (PCOS) [age 25.2+/- 4.7 years, with body mass index (BMI) 24.3 +/- 4.8 kg/m2; mean 6 SD] and 73 age-matched healthy females (BMI 22.3 +/- 3.3 kg/m2; mean +/- SD) were evaluated for the occurrence of features of metabolic syndrome according to the Adult Treatment Panel III.

Results: Overt metabolic syndrome (the presence of three and more risk factors) was not more common in PCOS women (1/64, 1.6%) than in healthy controls (0/73, 0%). On the other hand, in nearly 50% of PCOS women isolated features of metabolic syndrome, most often a decrease in high-density lipoprotein (HDL) cholesterol, were found. Women with at least one feature of metabolic syndrome were, in comparison with women without any of these features, significantly more obese (P = 0.0001), with lower insulin sensitivity (P = 0.05). When comparing PCOS women according to the degree of insulin sensitivity, as determined by euglycaemic clamp, isolated features of metabolic syndrome were found in 8/17 women above the upper quartile, compared with 11/16 women below the lower quartile of insulin sensitivity (P = 0.20).

Conclusions: Overt metabolic syndrome is only rarely encountered in young Czech females affected by PCOS but its isolated features are relatively frequent, both in young PCOS patients and in age-matched control women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Blood Pressure
  • Body Mass Index
  • Case-Control Studies
  • Cholesterol, HDL / metabolism
  • Czech Republic
  • Female
  • Humans
  • Hyperinsulinism / complications
  • Insulin Resistance
  • Metabolic Syndrome / complications*
  • Normal Distribution
  • Polycystic Ovary Syndrome / complications*
  • Risk Factors

Substances

  • Cholesterol, HDL